Colon - Adjuvant
Published: Wed Oct 5, 2011 Updated:Sat Oct 15, 2011
-
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
YJ Bang et al; January 28, 2012; 379(9813): 315-21
-
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
G Yothers et al, JCO Oct 1 2011; 29(28): 3678-3774
-
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer: A Systematic Review and Meta-analysis
JJ Biagi et al, JAMA 2011, 305(22):2335-2342
-
XELOXA Study: Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
DG Haller et al, JCO. Apr 10 2011; 29(11):1465-1471
-
MOSAIC Study: Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer
T Andre et al, JCO. July 1, 2009; 27(19):3109-3116
Sign-up for Our E-Newsletter
